Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2004

View Archived Issues

Isovaleramide advances into phase IIa study in migraine

Phase Ib study evaluates aerosolized surfactant therapy for asthma

Axonyx expands scope of phenserine phase IIb clinical trial

Confirmatory data supports phase II Resten-NG data

Five years exclusive Indian marketing rights for Nadoxin

Uni-Gold Recombigen HIV test receives FDA approval

Symbyax approved for bipolar depressive episodes

NDA submission for once-daily Allegra-D

ISIS-301012 enters phase I study for treatment of cardiovascular disease

Pharmion submits Vidaza NDA

Neurodex evaluated for pseudobulbar affect

Aventis scientists prepare and test new cathepsin K inhibitors

Kirin Brewery presents new inhibitors of Bcl-2/Bcl-xL with utility in cancer therapy

Novel libraries of antibacterial compounds prepared at Lion Bioscience

Mitsui Chemicals patent covers new agents for telomerase-mediated disorders

New antitumor azoles in early development at Sankyo

Coremed plans clinical trials for Alveair insulin technology

Alvesco NDA submission for persistent asthma

Shipments of TriNessa commence

DX-88 meets primary endpoints in phase I/II study

Japanese trials of HGF genetic medicine cleared to begin

Nascobal Nasal Spray submitted for FDA approval

AVI-4020 safe in phase I/II West Nile trial

Kyorin discontinues development of KRP-297

NDA filing for Arcoxia

Ivabradine has no adverse effects on the LVEF of patients with left ventricular dysfunction

Prolonged inhibition of spermatogenesis found with subcutaneous MENT implants

A novel triple therapy improves glucose metabolism in obese patients with type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...